This paper presents L. paracasei as the top-performing lactic acid bacterium for hypoglycemic-related in vitro properties among the tested panel. It showed gastric juice survival, bile salt tolerance, HT-29 colonization, digestive enzyme inhibition, and antioxidant-associated activity.
First-pass extracted concept
Lactobacillus paracasei
Candidate: concept label1 source documents4 linked claims
Live refresh every 5sNext refresh in 5s
Aliases
L. paracasei
Extracted Explainers
What the tool is doing
What problem it solves
Evidence Snippets
L. paracasei had a higher survival rate (82.78%) in gastric juice and good tolerance to bile salt, and can be colonized in HT-29 cells. L. paracasei had a remarkable inhibitive activity of b1-amylase (82.21%), b1-glucosidase (84.29%) and dipeptidyl peptidase 4 (42.51%).
Supporting Sources
Linked Claims
Lactobacillus paracasei showed the best hypoglycemic ability among the tested lactic acid bacteria according to PCA.
Quoted textsource-backed
According to the scores of the PCA, L. paracasei had the best hypoglycemic ability
Analytic hierarchy process ranked Lactobacillus paracasei as the best potential hypoglycemic probiotic.
Quoted textsource-backed
According to AHP, L. paracasei was the best potential hypoglycemic probiotic
Lactobacillus paracasei showed inhibitory activity against alpha-amylase, alpha-glucosidase, and dipeptidyl peptidase 4 in this study.
Quoted textsource-backed
L. paracasei had a remarkable inhibitive activity of b1-amylase (82.21%), b1-glucosidase (84.29%) and dipeptidyl peptidase 4 (42.51%).
Lactobacillus paracasei survived simulated gastric juice, tolerated bile salt, and colonized HT-29 cells in this study.
Quoted textsource-backed
L. paracasei had a higher survival rate (82.78%) in gastric juice and good tolerance to bile salt, and can be colonized in HT-29 cells.